0001140361-13-046219.txt : 20131213 0001140361-13-046219.hdr.sgml : 20131213 20131213194248 ACCESSION NUMBER: 0001140361-13-046219 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131211 FILED AS OF DATE: 20131213 DATE AS OF CHANGE: 20131213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VANDERVEEN RANDALL L CENTRAL INDEX KEY: 0001197539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 131277487 MAIL ADDRESS: STREET 1: 180 SPRINGMEADOW DRIVE CITY: UPPER ST. CLAIR STATE: PA ZIP: 15244 4 1 doc1.xml FORM 4 X0306 4 2013-12-11 0 0000069499 MYLAN INC. MYL 0001197539 VANDERVEEN RANDALL L 1500 CORPORATE DRIVE CANONSBURG PA 15317 1 0 0 0 Common Stock 2013-12-11 4 M 0 2052 14.82 A 29488 D Common Stock 2013-12-11 4 S 0 2052 42.281 D 27436 D Common Stock 2013-12-12 4 M 0 7948 14.82 A 35384 D Common Stock 2013-12-12 4 S 0 7948 42.00 D 27436 D Stock Option Right to Buy 14.82 2013-12-11 4 M 0 2052 0 D 2004-07-30 2014-07-30 Common Stock 2052 7948 D Stock Option Right to Buy 14.82 2013-12-12 4 M 0 7948 0 D 2004-07-30 2014-07-30 Common Stock 7948 0 D Represents the weighted average price of the reporting person's disposition of 2,052 shares in transactions ranging from $42.00 to $42.45. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4. This option exercise and the related sale of the underlying common stock were executed pursuant to a 10b5-1 trading plan dated November 25, 2013. /s/ Randall L. Vanderveen 2013-12-13